USA 101 , 66596663 (2004)
It also makes treatments work better
If the patient experienced a reduction in appetite and body weight that resulted from consuming a lower-calorie diet, the individuals appetite will increase back to baseline when the medication is stopped, making it harder to follow a lower calorie diet. 2
It was about GLP-1 weight-loss drugs
Tirzepatide May Be Considered When A physician determines that dual-receptor therapy may be appropriate based on weight, metabolic risk, prior treatment response, side-effect tolerance, and treatment goals
Dose adjustment considerations If dry mouth is severe and persistent, your provider may consider slowing dose escalation, reducing the current dose, or switching to a different GLP-1 medication